Biden is inheriting a depleted federal workforce requiring thousands of appointments, including many that need Senate confirmation.
Sometimes all it takes is a signature. Other cases require allies in Congress or the courts.
The president is expected to meet with pharmaceutical industry executives, who are opposed to the changes, on Tuesday.
Rachel Abrams of the New York Times and David Gura of Bloomberg join us to discuss the week’s business and economic news. This week, they talk about whether the Trump administration can meet any of its major pledges before its first 100 days. Also, Trump has signed a lot of executive orders, but are they doing […]
Wrapping up the week's business news with Catherine Rampell and Nela Richardson.
Trump wants to target the trade deficit, which he argues imperils U.S. workers.
The executive order's actual economic effects on U.S. steel and iron production are unclear.
Executive orders aren't all they're cracked up to be.